0001562180-18-003539.txt : 20180809
0001562180-18-003539.hdr.sgml : 20180809
20180809105941
ACCESSION NUMBER: 0001562180-18-003539
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180807
FILED AS OF DATE: 20180809
DATE AS OF CHANGE: 20180809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flynn Karen
CENTRAL INDEX KEY: 0001553599
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 181003967
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-08-07
false
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001553599
Flynn Karen
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
false
true
false
false
Sr VP & Chief Commercial Offic
Common Stock
2018-08-07
4
M
false
9458.00
21.22
A
31051.1476
D
Common Stock
2018-08-07
4
M
false
11000.00
25.145
A
42051.1476
D
Common Stock
2018-08-07
4
S
false
20458.00
116.23
D
21593.1476
D
Stock Options (Right to Buy)
25.145
2018-08-07
4
M
false
11000.00
0.00
D
2022-07-24
Common Stock
11000.00
20982.00
D
Stock Options (Right to Buy)
21.22
2018-08-07
4
M
false
9458.00
0.00
D
2022-02-21
Common Stock
9458.00
0.00
D
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $116.00 to $116.635 inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
This award vests in 4 equal annual installments beginning on 2/21/2013.
This award vests in 4 equal annual installments beginning on 7/24/2013.
Ryan Metz as Agent for Karen Flynn
2018-08-07